These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20861717)

  • 41. Management of angina pectoris: the role of spinal cord stimulation.
    Eckert S; Horstkotte D
    Am J Cardiovasc Drugs; 2009; 9(1):17-28. PubMed ID: 19178129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current Treatment of Stable Angina].
    Toggweiler S; Jamshidi P; Cuculi F
    Praxis (Bern 1994); 2015 Jun; 104(13):681-7. PubMed ID: 26081380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of patients undergoing enhanced external counterpulsation and spinal cord stimulation for refractory angina pectoris.
    Bondesson S; Pettersson T; Erdling A; Hallberg IR; Wackenfors A; Edvinsson L
    Coron Artery Dis; 2008 Dec; 19(8):627-34. PubMed ID: 19005298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranolazine for the management of coronary artery disease.
    Cheng JW
    Clin Ther; 2006 Dec; 28(12):1996-2007. PubMed ID: 17296457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angina pectoris: a review of current and emerging therapies.
    Parker JO
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S332-8. PubMed ID: 15603242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.
    Svorkdal N
    Semin Cardiothorac Vasc Anesth; 2004 Mar; 8(1):43-58. PubMed ID: 15372127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical therapy after successful percutaneous coronary revascularization.
    Hasdai D; Lerman A; Grill DE; Rihal CS; Holmes DR
    Ann Intern Med; 1999 Jan; 130(2):108-15. PubMed ID: 10068356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina.
    Galiñanes M; Loubani M; Sensky PR; Hassouna A; Cherryman GR; Leverment JN; Samani NJ
    Ann Thorac Surg; 2004 Jul; 78(1):122-8. PubMed ID: 15223416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinal cord stimulation significantly improves refractory angina pectoris-a local experience spinal cord stimulation in refractory angina.
    Chua R; Keogh A
    Heart Lung Circ; 2005 Mar; 14(1):3-7. PubMed ID: 16352244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Summary of the practice guideline 'Stable angina pectoris' (second revision) from the Dutch College of General Practitioners].
    Bouma M; Rutten FH; Bohnen AM; Wiersma T;
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2221-5. PubMed ID: 15568627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug therapy in angina pectoris].
    Follath F
    Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Angina pectoris in hypertensive patients].
    Ishii T; Otsuka Y; Kanmatsuse K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():333-6. PubMed ID: 15171394
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of stable angina.
    Ben-Dor I; Battler A
    Heart; 2007 Jul; 93(7):868-74. PubMed ID: 17569815
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological approaches of refractory angina.
    Giannopoulos AA; Giannoglou GD; Chatzizisis YS
    Pharmacol Ther; 2016 Jul; 163():118-31. PubMed ID: 27013345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelines.
    Cannon CP; Waheed S
    Rev Cardiovasc Med; 2009; 10 Suppl 1():S21-9. PubMed ID: 19898284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines.
    McGillion M; Arthur HM; Cook A; Carroll SL; Victor JC; L'allier PL; Jolicoeur EM; Svorkdal N; Niznick J; Teoh K; Cosman T; Sessle B; Watt-Watson J; Clark A; Taenzer P; Coyte P; Malysh L; Galte C; Stone J; ;
    Can J Cardiol; 2012; 28(2 Suppl):S20-41. PubMed ID: 22424281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
    Storey KM; Wang J; Garberich RF; Bennett NM; Traverse JH; Arndt TL; Schmidt CW; Henry TD
    Am J Cardiol; 2020 Aug; 129():1-4. PubMed ID: 32540170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):351-356. PubMed ID: 27358172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts.
    Schoebel FC; Frazier OH; Jessurun GA; De Jongste MJ; Kadipasaoglu KA; Jax TW; Heintzen MP; Cooley DA; Strauer BE; Leschke M
    Am Heart J; 1997 Oct; 134(4):587-602. PubMed ID: 9351724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stable coronary artery disease - medical treatment.
    Dąbrowski R; Dobrowolski M
    Pol Merkur Lekarski; 2017 Nov; 43(257):228-231. PubMed ID: 29231917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.